Emergence of quinolone-resistant Shigella dysenteriae type 1 in Canada.
D000328:Adult; D000416:Alberta / Q000453:epidemiology; D002939:Ciprofloxacin / Q000494:pharmacology / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D004405:Dysentery, Bacillary / Q000188:drug therapy*; D024841:Fluoroquinolones / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D012762:Shigella dysenteriae / Q000187:drug effects*
D024841:Fluoroquinolones; D002939:Ciprofloxacin